Journal of the American Chemical Society · 2007 · 558 citations · 28 references
Life SciencesCancer BiologyOncologyApoptosisMolecular OncologySignal TransductionApoptosis In CancerApoptosis ModulationApoptosis RegulationApoptotic SignalingCancer Cell SignalingTargeted Cancer TherapyAlpha Helix StabilityDirect ModulationP53 InactivationP53-mediated ApoptosisP53-mediated SignalingTherapeutic Target ValidationTumor Suppressor P53Tumor-targeting Peptides
The p53-hDM2 protein interaction is a validated therapeutic target in cancer. We report the synthesis of stabilized alpha-helix of p53 (SAH-p53) compounds that antagonize the p53-hDM2 interaction. We demonstrate that hydrocarbon stapling confers cellular permeability to a p53 peptide that is then capable of modulating transcriptional activity. The lead SAH-p53 compound triggers apoptosis in hDM2-overexpressing cancer cells by reactivating the native p53 signaling pathway. SAH-p53 is the first example of an all-hydrocarbon i, i+ 7 stabilized peptide that subverts cancer through direct modulation of a transcriptional pathway.
28
WAF1, a potential mediator of p53 tumor suppression
Wafik S. El‐Deiry, Takashi Tokino, Victor E. Velculescu et al. · Cell · 1993 · 8.4K citations
In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2
Lyubomir T. Vassilev, Binh Thanh Vu, Bradford Graves et al. · Science · 2004 · 4.7K citations
Medicine, Oncology, Pharmacology +15
Participation of p53 protein in the cellular response to DNA damage.
Michael B. Kastan, Onyinye Onyekwere, D Sidransky et al. · PubMed · 1991 · 3.8K citations
Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6
Elisheva Yonish-Rouach, Dalia Resnftzky, Joseph Lotem et al. · Nature · 1991 · 2.1K citations
Medicine, Hematology, Oncology +13